Catheter Precision Inc (AMEX:VTAK) does about 13.69M shares in volume on a normal day but saw 7301263 shares change hands in the recent trading day. The company now has a market cap of 3.05M USD. Its current market price is $0.24, marking an increase of 1.98% compared to the previous close of $0.24. The 52 week high reached by this stock is $8.40 whilst the lowest price level in 52 weeks is $0.16.
The consensus objective for the share price is $2.00, suggesting that the stock has a potential upside of 88.0% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 13, 2019 when Piper Jaffray downgraded the stock to “Neutral” and issued a price target of between $9 and $1.50.
The current price level is -14.31%, -12.27%, and -36.83% away from its SMA20, SMA50, and SMA200 respectively, with the VTAK price moving above the 50-day SMA on current market day. Catheter Precision Inc (VTAK) stock is down -10.10% over the week and 28.25% over the past month. Its price is -96.13% year-to-date and -46.34% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
To reach the target analysts have set, the stock logically needs to grow 88.0 percent from here.
Outstanding shares total 11.02M with insiders holding 7.99% of the shares and institutional holders owning 4.67% of the company’s common stock. The company has a return on investment of -126.65% and return on equity of -136.26%. The beta has a value of -0.76. Price to book ratio is 0.28 and price to sales ratio is 6.35.
